Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-11 Purchase | 2022-07-11 5:24 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 7,500 | $3.4 | $25,500 | 15,714 (Direct) | View |
| 2022-07-05 Purchase | 2022-07-05 5:32 pm | Verrica Pharmaceuticals Inc. | VRCA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,428,571 | $2.1 | $2,999,999 | 5,038,983 (Indirect) | View |
| 2022-07-05 Purchase | 2022-07-05 4:13 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 5,714 | $2.1 | $11,999 | 8,214 (Direct) | View |
| 2022-07-05 Purchase | 2022-07-05 4:13 pm | Verrica Pharmaceuticals Inc. | VRCA | White Ted CEO | 23,809 | $2.1 | $49,999 | 29,466 (Direct) | View |
| 2022-07-05 Purchase | 2022-07-05 4:12 pm | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 23,809 | $2.1 | $49,999 | 23,809 (Direct) | View |
| 2022-07-05 Purchase | 2022-07-05 4:11 pm | Verrica Pharmaceuticals Inc. | VRCA | Stalfort John A III Director | 238,095 | $2.1 | $500,000 | 700,205 (Direct) | View |
| 2022-07-05 Purchase | 2022-07-05 4:10 pm | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 4,761,904 | $2.1 | $9,999,998 | 15,389,481 (Indirect Direct) | View |
| 2021-12-02 Purchase | 2021-12-06 08:20 am | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 50,000 | $9.3581 | $467,905 | 10,627,577 (Indirect Direct) | View |
| 2021-06-04 Purchase | 2021-06-07 08:44 am | Verrica Pharmaceuticals Inc. | VRCA | White Ted CEO | 4,000 | $9.95 | $39,800 | 21,966 (Direct) | View |
| 2021-06-04 Purchase | 2021-06-07 08:42 am | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 2,500 | $9.79 | $24,475 | 2,500 (Direct) | View |
| 2021-06-04 Purchase | 2021-06-07 08:41 am | Verrica Pharmaceuticals Inc. | VRCA | DAVIS A BRIAN CFO | 5,000 | $9.89 | $49,450 | 12,900 (Direct) | View |
| 2021-03-25 Purchase | 2021-03-29 09:12 am | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 739,830 | $14.75 | $10,912,493 | 10,577,577 (Indirect Direct) | View |
| 2020-08-24 Purchase | 2020-08-26 4:40 pm | Verrica Pharmaceuticals Inc. | VRCA | Ballaron Craig Director | 10,000 | $8.8785 | $88,785 | 10,000 (Direct) | View |
| 2020-08-20 Purchase | 2020-08-21 07:44 am | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 20,000 | $9.09 | $181,800 | 9,837,747 (Indirect Direct) | View |
| 2020-08-18 Purchase | 2020-08-19 08:40 am | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 10,000 | $8.55 | $85,500 | 9,817,747 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-09 Option Award | 2022-06-13 4:20 pm | N/A 2032-06-08 | Verrica Pharmaceuticals Inc. | VRCA | Ballaron Craig Director | 10,384 | $0 | 10,384 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:18 pm | N/A 2032-06-08 | Verrica Pharmaceuticals Inc. | VRCA | PRYGOCKI MARK A SR Director | 10,384 | $0 | 10,384 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:17 pm | N/A 2032-06-08 | Verrica Pharmaceuticals Inc. | VRCA | Eichenfield Lawrence Director | 10,384 | $0 | 10,384 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:16 pm | N/A 2032-06-08 | Verrica Pharmaceuticals Inc. | VRCA | Nguyen Diem Director | 10,384 | $0 | 10,384 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-25 4:37 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-25 4:36 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-25 4:33 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry CFO | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-25 4:33 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-25 4:30 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | White Ted CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-14 9:15 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 739,830 | $0 | 8,889,224 (Indirect) | View |
| 2021-07-16 Option Award | 2021-07-20 6:04 pm | N/A 2031-07-15 | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry CFO | 125,000 | $0 | 125,000 (Direct) | View |
| 2021-06-10(A) Option Award | 2021-06-17 4:36 pm | N/A 2031-06-09 | Verrica Pharmaceuticals Inc. | VRCA | PRYGOCKI MARK A SR Director | 8,109 | $0 | 8,109 (Direct) | View |
| 2021-06-10(A) Option Award | 2021-06-17 4:35 pm | N/A 2031-06-09 | Verrica Pharmaceuticals Inc. | VRCA | Nguyen Diem Director | 8,109 | $0 | 8,109 (Direct) | View |
| 2021-06-10(A) Option Award | 2021-06-17 4:33 pm | N/A 2031-06-09 | Verrica Pharmaceuticals Inc. | VRCA | Ballaron Craig Director | 8,109 | $0 | 8,109 (Direct) | View |
| 2021-06-10(A) Option Award | 2021-06-17 4:31 pm | N/A 2031-06-09 | Verrica Pharmaceuticals Inc. | VRCA | Eichenfield Lawrence Director | 8,109 | $0 | 8,109 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:59 pm | N/A 2031-06-09 | Verrica Pharmaceuticals Inc. | VRCA | Ballaron Craig Director | 5,834 | $0 | 5,834 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:58 pm | N/A 2031-06-09 | Verrica Pharmaceuticals Inc. | VRCA | PRYGOCKI MARK A SR Director | 5,834 | $0 | 5,834 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:56 pm | N/A 2031-06-09 | Verrica Pharmaceuticals Inc. | VRCA | Eichenfield Lawrence Director | 5,834 | $0 | 5,834 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:55 pm | N/A 2031-06-09 | Verrica Pharmaceuticals Inc. | VRCA | Nguyen Diem Director | 5,834 | $0 | 5,834 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 5:06 pm | N/A 2031-02-28 | Verrica Pharmaceuticals Inc. | VRCA | White Ted CEO | 160,000 | $0 | 160,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 5:05 pm | N/A 2031-02-28 | Verrica Pharmaceuticals Inc. | VRCA | DAVIS A BRIAN CFO | 65,000 | $0 | 65,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 5:03 pm | N/A 2031-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 5:02 pm | N/A 2031-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe Chief Commercial Officer | 65,000 | $0 | 65,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 5:01 pm | N/A 2031-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 65,000 | $0 | 65,000 (Direct) | View |